Inotuzumab Ozogamicin (InO) Combined with UKALL-R3 Modified Chemotherapy in Pediatric Patients with B-Cell Precursor CD22+ Acute Lymphoblastic Leukemia (BCP-ALL) - Results from the ITCC-059 Phase 1B Trial
Autor: | Pennesi, Edoardo *, Brivio, Erica *, Ammerlaan, Anneke C.J. *, Jiang, Yilin *, van der Velden, Vincent H.J. *, Beverloo, Berna *, Sleight, Barbara *, Rives, Susana *, Díaz de Heredia Rubio, Cristina *, Bautista Sirvent, Francisco J. *, Rubio-San-Simón, Alba *, Rialland, Fanny *, Rizzari, Carmelo *, Bielorai, Bella *, Petit, Arnaud *, Bruno, Bénédicte *, Øra, Ingrid *, Nilsson, Anna *, Engstler, Gernot *, Rossig, Claudia *, Brethon, Benoit *, Locatelli, Franco, Zwaan, Christian M. * |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:8976-8978 |
Databáze: | ScienceDirect |
Externí odkaz: |